Azenta, Inc. (NASDAQ:AZTA) Short Interest Update

Azenta, Inc. (NASDAQ:AZTA) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 4,340,000 shares, a decrease of 9.8% from the October 15th total of 4,810,000 shares. Based on an average daily trading volume, of 552,300 shares, the days-to-cover ratio is presently 7.9 days. Currently, 9.1% of the company’s stock are sold short.

Insider Buying and Selling at Azenta

In other Azenta news, CFO Herman Cueto sold 1,595 shares of the business’s stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the sale, the chief financial officer now owns 24,604 shares in the company, valued at $1,074,702.72. The trade was a 6.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.77% of the stock is currently owned by insiders.

Institutional Trading of Azenta

Institutional investors and hedge funds have recently bought and sold shares of the stock. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of Azenta by 1.9% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after acquiring an additional 100,826 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Azenta by 16.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after purchasing an additional 421,719 shares during the period. State Street Corp lifted its holdings in shares of Azenta by 0.4% in the third quarter. State Street Corp now owns 1,686,993 shares of the company’s stock valued at $81,718,000 after purchasing an additional 6,398 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Azenta by 16.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares during the period. Finally, Royce & Associates LP grew its holdings in shares of Azenta by 7.8% during the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after buying an additional 53,584 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Evercore ISI dropped their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Needham & Company LLC dropped their price objective on shares of Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $63.60.

Azenta Stock Down 2.6 %

Shares of AZTA stock traded down $1.12 during mid-day trading on Friday, hitting $41.51. 525,163 shares of the stock traded hands, compared to its average volume of 521,385. Azenta has a twelve month low of $40.24 and a twelve month high of $69.16. The company’s 50-day simple moving average is $45.56 and its 200-day simple moving average is $50.44.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.13 earnings per share. Equities analysts expect that Azenta will post 0.4 earnings per share for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.